[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.

The last time you heard of Moderna (MRNA) was likely because of its mRNA Covid vaccine, but that same tech, once administered en masse, could soon become a life-changing, specialized cure for cancers. The recent breakthrough came from its intismeran autogene, or more formally mRNA-4157/V940, Moderna's personalized mRNA cancer therapy developed alongside Merck (MRK), which met its primary recurrence-free survival endpoint in a late-stage melanoma trial.

The result sent MRNA stock soaring 176.97% on Wednesday because intismeran autogene is designed around the unique mutations found in an individual patient's tumor and trains the immune system to recognize and attack...

Fundamentals

See More
  • Market Capitalization, $K 57,941,120
  • Shares Outstanding, K 399,236
  • Annual Sales, $ 1,944 M
  • Annual Income, $ -2,822 M
  • EBIT $ -3,320 M
  • EBITDA $ -3,172 M
  • 60-Month Beta 0.91
  • Price/Sales 27.38
  • Price/Cash Flow N/A
  • Price/Book 7.87

Options Overview Details

View History
  • Implied Volatility 96.93% (-12.84%)
  • Historical Volatility 308.52%
  • IV Percentile 97%
  • IV Rank 48.66%
  • IV High 140.04% on 08/19/26
  • IV Low 56.07% on 08/22/25
  • Expected Move (DTE 5) 17.04 (11.74%)
  • Put/Call Vol Ratio 0.90
  • Today's Volume 718,594
  • Volume Avg (30-Day) 120,674
  • Put/Call OI Ratio 1.53
  • Today's Open Interest 998,456
  • Open Int (30-Day) 626,915
  • Expected Range 128.09 to 162.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-1.47
  • Number of Estimates 8
  • High Estimate $-0.80
  • Low Estimate $-3.32
  • Prior Year $-0.51
  • Growth Rate Est. (year over year) -188.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.66 +175.60%
on 08/03/26
176.66 -17.85%
on 08/19/26
+85.47 (+143.26%)
since 07/21/26
3-Month
43.90 +230.59%
on 06/02/26
176.66 -17.85%
on 08/19/26
+97.87 (+207.09%)
since 05/21/26
52-Week
22.28 +551.39%
on 11/21/25
176.66 -17.85%
on 08/19/26
+118.91 (+453.51%)
since 08/21/25

Most Recent Stories

More News
2 Biotech Stocks Shaping Up for Major Breakouts

Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts.

NTRA : 332.03 (+2.21%)
MRK : 152.55 (+2.39%)
IBB : 213.56 (+1.29%)
LLY : 1,255.40 (+0.88%)
MRNA : 145.13 (+8.86%)
MarketBeat Week in Review – 08/17 - 08/21

Stocks fell this week as Treasury bond buybacks, oil prices, and Walmart earnings weighed on markets, while Bitcoin rallied; MarketBeat analysts cover Moderna, NVIDIA, Meta, RTX, and more.

BDC : 122.46 (-1.15%)
NVDA : 214.72 (-0.98%)
GOOGL : 344.82 (+1.22%)
META : 549.90 (+0.75%)
AMAT : 492.32 (-0.78%)
BE : 201.45 (-0.51%)
MRK : 152.55 (+2.39%)
TMC : 4.79 (+20.65%)
OKTA : 135.14 (+0.73%)
SQM : 81.96 (+4.47%)
SKHY : 163.41 (+0.20%)
OSW : 26.68 (+2.30%)
Stocks Settle Higher as Crude Oil Prices Stabilize

The S&P 500 Index ($SPX ) (SPY ) closed up by +0.43% on Friday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +0.98%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.33%. E-mini...

MSTR : 119.25 (+6.10%)
TER : 375.74 (-1.93%)
AMAT : 492.32 (-0.78%)
B : 47.60 (+2.87%)
CNP : 38.77 (-3.56%)
SRE : 82.89 (-5.14%)
MRK : 152.55 (+2.39%)
$IUXX : 29,308.86 (+0.33%)
COIN : 186.49 (+8.20%)
ZNU26 : 108-125 (+0.12%)
TSLA : 362.86 (+5.14%)
ESU26 : 7,687.75 (-0.05%)
Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.

Moderna's cancer treatment could treat more than just Melanoma, though the stock's momentum is already stalling. Should you still buy the dip?

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)
Unusual Options Activity Shows 1 Institutional Trader Is Making a Big Bet on PG&E Stock

Yesterday’s unusual options activity revealed a massive 20,000-contract bull call spread on Pacific Gas & Electric (PCG). The low-risk, high-reward October trade risks $1.2 million for a potential $8.8...

PCG : 17.60 (-2.00%)
OWL : 11.67 (+2.37%)
MRNA : 145.13 (+8.86%)
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough

NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough.

$NASX : 26,180.45 (+0.43%)
MRK : 152.55 (+2.39%)
NVAX : 8.94 (+6.18%)
MRNA : 145.13 (+8.86%)
XBI : 165.73 (+1.44%)
SNY : 45.85 (+1.55%)
BNTX : 116.57 (+5.12%)
Stocks Supported as Crude Oil Stabilizes

The S&P 500 Index ($SPX ) (SPY ) is up by +0.38% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.09%. E-mini S&P futures (ESU26...

MSTR : 119.25 (+6.10%)
TER : 375.74 (-1.93%)
AMAT : 492.32 (-0.78%)
B : 47.60 (+2.87%)
GLXY : 23.64 (+0.72%)
MRK : 152.55 (+2.39%)
$IUXX : 29,308.86 (+0.33%)
COIN : 186.49 (+8.20%)
ZNU26 : 108-125 (+0.12%)
ESU26 : 7,687.75 (-0.05%)
STX : 850.00 (-0.03%)
WDC : 459.44 (-2.05%)
Moderna’s 177% Surge Has Investors Asking What Comes Next

Moderna shares surged 177% after its melanoma vaccine, developed with Merck, outperformed an established therapy in a late-stage trial, triggering a massive short squeeze.

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)
Trump’s Moderna Trade Up Over 200% After Historic mRNA Cancer Vaccine Trial

Shares of Moderna ($MRNA) closed up nearly 177% at $174.38 on August 19 after the company and Merck ($MRK) announced positive Phase 3 results for their personalized mRNA cancer therapy, pushing Moderna's...

MRK : 152.55 (+2.39%)
MRNA : 145.13 (+8.86%)
Stocks Settle Lower as Rising Crude Prices Spur Inflation Fears

The S&P 500 Index ($SPX ) (SPY ) closed down by -0.87% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.72%....

ALK : 40.41 (+0.57%)
MSTR : 119.25 (+6.10%)
UAL : 113.17 (+1.31%)
DE : 647.47 (+4.27%)
GLXY : 23.64 (+0.72%)
$IUXX : 29,308.86 (+0.33%)
COIN : 186.49 (+8.20%)
ZNU26 : 108-125 (+0.12%)
OXY : 61.30 (-0.36%)
ESU26 : 7,687.75 (-0.05%)
FANG : 210.72 (-0.14%)
NCLH : 17.24 (+2.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 185.98
2nd Resistance Point 172.72
1st Resistance Point 158.93
Last Price 145.13
1st Support Level 131.88
2nd Support Level 118.62
3rd Support Level 104.83

See More

52-Week High 176.66
Last Price 145.13
Fibonacci 61.8% 117.69
Fibonacci 50% 99.47
Fibonacci 38.2% 81.25
52-Week Low 22.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.